Fierce Healthcare August 6, 2024
Emma Beavins

The Food and Drug Administration has announced the technical experts and industry representatives that will take part in its new Digital Health Advisory Committee (DHAC). The committee will address the use of generative AI in medical devices at its first meeting in November.

FDA announced in October 2023 that it would create a digital health advisory committee to inform FDA on considerations for digital health technologies such as AI/ML, virtual reality, wearables, digital therapeutics and remote patient monitoring. DHAC will also weigh in on issues like decentralized clinical trials, patient-generated health data, real-world data, real-world evidence and cybersecurity, the FDA’s website says.

The FDA put out an open call for technical experts on digital health technologies to apply to sit...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

Continue Reading

 
Topics: AI (Artificial Intelligence), Digital Health, FDA, Govt Agencies, Technology
Related Articles:
Marty Makary, Who Made His Name Bashing the Medical Establishment, May Soon Lead FDA
Gutting FDA Won't Make America Healthy
Google’s Pixel Watch 3 Loss of Pulse Detection Feature Receives FDA Clearance
FDA Annual Flu Vaccine Meeting and CDC’s ‘Wild to Mild’ Campaign Canceled
Supporting the Development of Drugs for Rare Diseases — The Importance of Regulatory Transparency

Share This Article